Lactulosum
This medicine should always be taken exactly as described in this package leaflet for the patient, or as directed by a doctor or pharmacist.
Lactulosum Forte Polfarmex contains the active substance lactulose, a laxative. It softens the stool and facilitates its passage by drawing water into the intestine. It is not absorbed by the body.
Lactulosum Forte Polfarmex is used to treat constipation (slow bowel movements, hard and dry stools) and to soften the stool, for example:
Lactulosum Forte Polfarmex is also used to treat hepatic encephalopathy (a liver disease causing confusion, tremors, decreased level of consciousness, including coma).
Before starting to take Lactulosum Forte Polfarmex, the doctor or pharmacist should be consulted if the patient has any diseases, especially:
Lactulosum Forte Polfarmex should not be taken if:
In diabetic patients also being treated for hepatic encephalopathy, the dose of Lactulosum Forte Polfarmex will be higher. This higher dose may contain a large amount of sugar. Therefore, it may be necessary to adjust the dose of antidiabetic medicines.
It should be taken into account that during treatment, the bowel movement reflex may be disturbed.
Chronic intake of unadjusted doses (appearance of more than 2-3 soft stools per day) or abuse may lead to diarrhea and electrolyte disturbances.
During the use of laxative medicines, it is recommended to drink an adequate amount of fluids (about 2 L/day, i.e., 6-8 glasses).
In case of taking Lactulosum Forte Polfarmex for several days and no improvement or worsening of symptoms, a doctor should be contacted.
In special cases, a doctor may prescribe Lactulosum Forte Polfarmex for use in children, infants, or newborns. Lactulosum Forte Polfarmex may be given to infants and young children only after a doctor's recommendation, as it may disrupt the natural bowel movement reflex.
In such cases, treatment will be strictly supervised by a doctor.
The doctor or pharmacist should be informed about all medicines the patient is currently taking or has recently taken, as well as any medicines the patient plans to take.
Lactulosum Forte Polfarmex can be taken with or without food. There are no restrictions on food or drink intake.
Lactulosum Forte Polfarmex can be taken during pregnancy and breastfeeding.
No effect on fertility is anticipated.
If the patient is pregnant or breastfeeding, thinks she may be pregnant, or plans to have a child, she should consult a doctor or pharmacist before taking this medicine.
Lactulosum Forte Polfarmex has no influence or negligible influence on the ability to drive and use machines.
This medicine contains 1.386 mg of alcohol (ethanol) per 1 mL of syrup. In the case of the maximum daily dose, the amount of alcohol is equivalent to:
Lactulosum Forte Polfarmex may contain lactose, galactose, and small amounts of fructose.If the patient has been diagnosed with intolerance to some sugars, the patient should consult a doctor before taking the medicine.
This medicine should always be taken as directed by a doctor or pharmacist. In case of doubt, the doctor or pharmacist should be consulted.
Oral administration.
The medicine should be swallowed quickly. It should not be kept in the mouth.
The medicine should be taken at the same time of day.
The dose can be given once a day, e.g., during breakfast, or in two divided doses.
After a few days, the initial dose may be adjusted to a maintenance dose based on the response to treatment. The therapeutic effect may occur after a few days (2-3 days) of treatment.
Initial daily dose | Maintenance daily dose | |
Adults and adolescents | 15-45 mL | 15-30 mL |
Children (7-14 years) | 15 mL | 10-15 mL |
Children (1-6 years) | 5-10 mL | 5-10 mL |
Infants under 1 year | up to 5 mL | up to 5 mL |
Laxative medicines in children, infants, and newborns should be used in special cases and under medical supervision, as they may disrupt the natural bowel movement reflex.
Lactulosum Forte Polfarmex should not be given to children (under 14 years of age) without consulting a doctor, who will recommend the medicine and ensure treatment supervision.
The initial dose for hepatic encephalopathy is 30-45 mL 3-4 times a day.
Dosing may be modified to a maintenance dose so that the patient has 2 to 3 soft stools per day.
There are no available data on the use in children (under 18 years of age) with hepatic encephalopathy.
There are no special dosing recommendations.
In case of overdose, diarrhea, electrolyte loss, and abdominal pain may occur.
In case of taking a higher dose than recommended, a doctor or pharmacist should be contacted.
In case of a missed dose, the next dose should be taken at the usual time.
A double dose should not be taken to make up for a missed dose.
Treatment should not be stopped or changed without consulting a doctor.
In case of any further doubts about the use of the medicine, a doctor or pharmacist should be consulted.
Like all medicines, Lactulosum Forte Polfarmex can cause side effects, although not everybody gets them.
During treatment with Lactulosum Forte Polfarmex, the following side effects have been reported:
Very common(may affect more than 1 in 10 people)
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Frequency not known(frequency cannot be estimated from the available data)
During the first few days of treatment, bloating may occur. It usually disappears after a few days.
In case of taking higher doses than recommended, abdominal pain and diarrhea may occur.
In such a case, the dose should be reduced.
In case of taking high doses for a longer period (usually only in the treatment of hepatic encephalopathy), the patient may experience electrolyte disturbances due to diarrhea.
If any side effects occur, including those not listed in this package leaflet, the doctor or pharmacist should be informed. Side effects can be reported directly to the Department of Pharmacovigilance of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
PL-02-222 Warsaw
Tel.: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, more information can be collected on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
This medicine should not be used after the expiry date stated on the carton and bottle after:
“EXP”.
Shelf-life after first opening the bottle: 18 months.
The expiry date refers to the last day of the month stated.
Do not store above 25°C.
Medicines should not be disposed of via wastewater or household waste. A pharmacist should be asked how to dispose of medicines no longer required. This will help protect the environment.
The active substance of the medicine is lactulose in the form of liquid lactulose. 1 mL of the medicine contains 667 mg of lactulose.
The other ingredients are:
orange flavor (contains orange oil, ethanol, water), purified water.
Lactulosum Forte Polfarmex is a clear syrup, yellow to light brown-yellow in color, with a characteristic orange flavor.
200 mL of Lactulosum Forte Polfarmex syrup is in an orange glass type III bottle, with an aluminum cap, with a guarantee ring and an LDPE seal, placed in a cardboard box with a patient leaflet and a measuring cup made of polypropylene with a scale to facilitate measuring the correct amount of medicine 2.5 mL, 5 mL, 10 mL, 15 mL.
Polfarmex S.A.
ul. Józefów 9
99-300 Kutno
Poland
Tel.: +48 24 357 44 44
Fax: +48 24 357 45 45
e-mail: polfarmex@polfarmex.pl
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.